IC

Kymera Therapeutics, Inc. (KYMR)

NASDAQ: KYMR · Real-Time Price · USD

32.17

+2.10 (6.98%)

At close: May 12, 2025, 4:00 PM

32.05

-0.12 (-0.37%)

After-hours: May 12, 2025, 4:09 PM EDT

Kymera Therapeutics Employees

Kymera Therapeutics had 188 employees as of December 31, 2024. The number of employees increased by 1 or 0.53% compared to the previous year.

Employees

188

Change (1Y)

1

Growth (1Y)

0.53%

Revenue / Employee

$313,218

Profits / Employee

-$1,281,287

Market Cap

2.09B

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	188	1	0.53%
Dec 31, 2023	187	20	11.98%
Dec 31, 2022	167	26	18.44%
Dec 31, 2021	141	66	88.00%
Dec 31, 2020	75	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	94,300
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

KYMR News

3 days ago - Kymera Therapeutics, Inc. (KYMR) Q1 2025 Earnings Call Transcript - Seeking Alpha
3 days ago - Kymera Therapeutics Expands Industry Leading Immunology Pipeline with New First-in-Class, Oral IRF5 Degrader Program with Potential to Address Multiple Immuno-Inflammatory Diseases - GlobeNewsWire
3 days ago - Kymera Therapeutics Announces First Quarter 2025 Financial Results and Provides a Business Update - GlobeNewsWire
5 days ago - Kymera Therapeutics to Participate in Fireside Chat at the BofA Securities 2025 Health Care Conference - GlobeNewsWire
20 days ago - Kymera Therapeutics Announces First Patient Dosed in BROADEN Phase 1b Atopic Dermatitis Clinical Trial of KT-621, a First-in-Class Oral STAT6 Degrader - GlobeNewsWire
4 weeks ago - Kymera Therapeutics Appoints Noah Goodman as Chief Business Officer - GlobeNewsWire
2 months ago - Kymera Therapeutics, Inc. (KYMR) Q4 2024 Earnings Call Transcript - Seeking Alpha
2 months ago - Kymera Therapeutics to Participate in Upcoming March Investor Conferences - GlobeNewsWire